Author Correction Published Regarding Global Chikungunya Burden Study
A correction has been issued for a recent study detailing the global burden of chikungunya virus infections and assessing the potential impact of vaccination campaigns. The original research, published in The Lancet, significantly quantified the disease’s impact and underscored the potential public health benefits of widespread vaccination.
The study, led by Gabriel Ribeiro dos Santos of the Coalition for Epidemic Preparedness Innovations (CEPI) in London, UK, and involving a collaborative network of researchers across Africa, Europe, and North America, initially estimated a substantial global burden of chikungunya. The correction addresses details within the author affiliations and lists, ensuring accurate depiction of the contributions from institutions including Sokoine University of Agriculture (Tanzania), Rwanda Military Teaching Hospital and University of Rwanda, York University (Canada), University of Ghana, University of Ilorin (Nigeria), Pasteur Network (France), Paris Cité University, Institut Pasteur (france), Kilimanjaro christian Medical university College (Tanzania), Qatar University, and the Institut Pasteur’s Modelling of Infectious Diseases Unit. key researchers involved in the collaborative effort include Christinah Mukandavire, Arminder Deol, Danny Scarponi, Leonard E.G. Mboera, Eric Seruyange, Mathieu JP Poirier, Samuel Bosomprah, Augustine O. Queen, Koussay Dellagi, Nathanael Hozé, Jaffu Chilongola, Gheyath K. Nasrallah, and Simon Cauchemez.
Chikungunya virus, transmitted primarily by Aedes aegypti and Aedes albopictus mosquitoes, causes debilitating joint pain, fever, and rash. While typically not fatal, the chronic pain associated with the infection can significantly impair quality of life for months or even years. The study’s findings are crucial for informing public health strategies, notably in regions where chikungunya is endemic or poses a significant outbreak risk. The corrected author details ensures proper attribution for this important work,which provides a foundation for evaluating the feasibility and impact of future vaccination programs aimed at controlling the spread of this debilitating disease.
